| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.4 |